COVID-19 "Rebound" associated with nirmatrelvir/ritonavir pre-hospital therapy.
J Infect. 2022 Oct;85(4):436-480. doi: 10.1016/j.jinf.2022.06.011. Epub 2022 Jun 17.
J Infect. 2022.
PMID: 35718206
Free PMC article.
No abstract available.